RDX expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.506220E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.198970E-01
Normal-vs-Stage2
1.880480E-02
Normal-vs-Stage3
1.207210E-01
Normal-vs-Stage4
6.983700E-02
Stage1-vs-Stage2
5.484400E-01
Stage1-vs-Stage3
6.644400E-02
Stage1-vs-Stage4
3.093400E-01
Stage2-vs-Stage3
1.544280E-03
Stage2-vs-Stage4
6.191200E-01
Stage3-vs-Stage4
5.387800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.243990E-02
Normal-vs-AfricanAmerican
3.711000E-01
Normal-vs-Asian
3.596400E-03
Caucasian-vs-AfricanAmerican
1.650600E-01
Caucasian-vs-Asian
5.646300E-02
AfricanAmerican-vs-Asian
3.325800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.422350E-02
Normal-vs-Female
2.286400E-02
Male-vs-Female
2.654200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.615600E-02
Normal-vs-Age(41-60Yrs)
1.101950E-01
Normal-vs-Age(61-80Yrs)
5.177400E-03
Normal-vs-Age(81-100Yrs)
6.781300E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.387400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.937400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.993400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.600400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.620200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.676400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.857600E-02
Normal-vs-Daily Drinker
8.025600E-04
Normal-vs-Weekly Drinker
5.138200E-03
Normal-vs-Occasional Drinker
1.077400E-01
Normal-vs-Social Drinker
7.360000E-02
Non Drinker-vs-Daily Drinker
1.468760E-01
Non Drinker-vs-Weekly Drinker
3.721000E-01
Non Drinker-vs-Occasional Drinker
6.226600E-01
Non Drinker-vs-Social Drinker
8.109400E-01
Daily Drinker-vs-Weekly Drinker
5.827600E-01
Daily Drinker-vs-Occasional Drinker
7.320400E-02
Daily Drinker-vs-Social Drinker
9.786300E-02
Weekly Drinker-vs-Occasional Drinker
2.149800E-01
Weekly Drinker-vs-Social Drinker
2.998800E-01
Occasional Drinker-vs-Social Drinker
8.217800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.494600E-01
Normal-vs-Grade 2
1.851850E-01
Normal-vs-Grade 3
1.976810E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.416800E-01
Grade 1-vs-Grade 3
2.333600E-01
Grade 1-vs-Grade 4
2.494600E-01
Grade 2-vs-Grade 3
1.729830E-01
Grade 2-vs-Grade 4
1.851850E-01
Grade 3-vs-Grade 4
1.976810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.123900E-03
Normal-vs-NonDiabetic
1.344320E-02
Diabetic-vs-NonDiabetic
4.976000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.237810E-02
Normal-vs-NoPancreatitis
1.175970E-02
Pancreatitis-vs-NoPancreatitis
5.349000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.763510E-02
Normal-vs-N1
2.000500E-02
N0-vs-N1
6.214200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.452200E-02
Normal-vs-TP53-NonMutant
1.991770E-02
TP53-Mutant-vs-TP53-NonMutant
4.648200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
